HIGHLIGHTS
- who: Jia Meng Pang et al. from the Department of Medical Science, Hua University, Hsinchu, Institute of have published the paper: MicroRNA-708 emerges as a potential candidate to target undruggable NRAS, in the Journal: PLOS ONE of 21/04/2023
- what: The authors report using miRNA-708 which targets the distinct 3` untranslated region (3`UTR) of NRAS to develop miRNA-based precision medicine to treat NRAS mutation-driven cancers. The study provides new insights regarding the use of microRNA to overcome the limitation of small_molecule- or protein-based drugs to target those traditionally . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.